Yishan Zhou | Cardiology | Most Reader’s Article Award

Published on by Cardiology and Cardiovascular Medicine

Ms. Yishan Zhou | Cardiology | Most Reader's Article Award

The Seventh Clinical College of Guangzhou University of Chinese Medicine | China

Ms. Zhou Yishan is a dedicated researcher in Chinese Internal Medicine whose academic and professional journey reflects consistent excellence and a strong commitment to advancing integrative medical practice. She earned her Bachelor of Medicine in Clinical Medicine (Integrated Chinese and Western Medicine) from Guangzhou Medical University, followed by a Master of Medicine in Chinese Internal Medicine (Nephrology) from Guangzhou University of Chinese Medicine. During her postgraduate studies, she served as a core project member in the Sanming Project of Medicine in Shenzhen, contributing to research initiatives focused on clinical nephrology. She also played a key role in the Baoan District Association of Chinese Medicine Promotion Project, working on the clinical evaluation of the Yiqi Huoxue Fumigation-Wash formula for preventing early failure of autogenous arteriovenous fistulas, demonstrating her commitment to improving patient outcomes through evidence-based traditional therapies. Earlier in her academic career, she served as a Research Assistant at the National Center for Respiratory Medicine, supporting Professor Sun’s team through data collection, literature reviews, and preparation of research materials, which strengthened her multidisciplinary foundation. Her achievements have been recognized through honors such as Outstanding Graduate and University Merit Student, along with multiple First-Class and Second-Class Scholarships. With 2 published documents, 11 citations, and an h-index of 1, Ms. Zhou continues to build a promising research profile grounded in rigorous clinical investigation and integrative medical innovation.

Profile: Scopus

Featured Publications

Zhou, Y., Zou, Y., Cao, Y., et al. (2025). The association between the cardiometabolic index and hyperuricemia: 2011–2016 NHANES. Frontiers in Endocrinology, 16, 1545968.

Cao, Y., Zhou, Y., Zhong, Y., Liao, X., Chen, X., & Pi, Y. (2024). Association between oxidative balance score in adults with and without chronic kidney disease: 2011–2028 NHANES. Frontiers in Nutrition, 11, 1374719.

Zhou, Y., et al. (2025). Clinical observation on Yiqi Huoxue Fumigation-Wash Formula for preventing early failure of autogenous arteriovenous fistula. Guiding Journal of Traditional Chinese Medicine and Pharmacy, 31(08), 114–120, 127.

Zhou, Y., et al. (2024). Exploration on the clinical application of Ephedrae Herba in stimulating Yang Qi. Journal of Guangzhou University of Traditional Chinese Medicine, 41(01), 234–239.

Umit Yasar Sinan | Pulmonary Hypertension | Editorial Board Member

Published on by Cardiology and Cardiovascular Medicine

Assoc. Prof. Dr. Umit Yasar Sinan | Pulmonary Hypertension | Editorial Board Member

Istanbul University-Cerrahpasa Cardiology Institute | Turkey

Umit Yaşar Sinan is an accomplished cardiovascular specialist whose career reflects sustained academic excellence, broad clinical expertise, and meaningful contributions to contemporary cardiology. After completing rigorous medical and cardiology training at leading institutions, he advanced rapidly through academic ranks and currently serves as an Associate Professor of Cardiology, where he is recognized for his dedication to research, teaching, and advanced patient care. His international experience includes focused work in adult congenital heart disease and pulmonary hypertension at a major UK referral center, strengthening his profile in complex cardiac conditions. Over the years, he has cultivated deep clinical interests spanning echocardiography, invasive cardiology, structural heart disease, pulmonary hypertension, adult congenital heart disease, heart failure, and atherosclerosis. His scholarly productivity is reflected in 90 scientific documents, which have collectively received 559 citations from 531 sources, supporting an h-index of 14 an indicator of his growing influence in cardiovascular research. He remains actively engaged in professional communities, holding memberships and leadership roles across prominent international and national cardiology societies, where he contributes to collaborative initiatives in acute cardiovascular care, imaging, valvular heart disease, congenital heart disease, and pulmonary vascular disorders. Through this blend of academic leadership, clinical depth, and research impact, he continues to shape advancements in cardiology both within his institution and across the broader scientific community.

Profile: Scopus | Orcid

Featured Publications

Yaylalı, Y. T., Yağmur, B., Sinan, Ü. Y., Meriç, M., Başarıcı, İ., Kılıçkıran Avcı, B., Şenol, H., Nalbantgil, S., Küçükoğlu, S., & Öngen, Z. (2023). Risk assessment tool implementation in congenital heart disease-associated pulmonary arterial hypertension. Anatolian Journal of Cardiology, 27(8), 479-485.

Kocabaş, U., Ergin, İ., Kıvrak, T., Yılmaz Öztekin, G. M., Tanık, V. O., Özdemir, İ., Avcı Demir, F., Doğduş, M., Şen, T., Altınsoy, M., Üstündağ, S., Urgun, Ö. D., Sinan, Ü. Y., Uygur, B., Yeni, M., & Özçalık, E. (2023). Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction. ESC Heart Failure, 10(6), 3677-3689.

Akyıldız Akçay, F., Sinan, Ü. Y., Gürbüz, D. Ç., Şafak, Ö., Kaya, H., Yüksek, Ü., & Zoghi, M. (2023). Gender-related differences in patients with acute heart failure: Observation from the Journey Heart Failure-Turkish Population Study. Anatolian Journal of Cardiology, 27(11), 639-649.

Sinan, U. Y., Serin, E., Keskin-Meriç, B., & Arat-Ozkan, A. (2023). Cre8 drug eluting stent performance in daily cardiology practice. IMR Press, 24(2), 53.

Şabanoğlu, C., Sinan, Ü. Y., Akboğa, M. K., Çoner, A., Gök, G., Kocabaş, U., Bekar, L., Gazi, E., Cengiz, M., Kılıç, S., İnanç, İ. H., Çakmak, H. A., & Zoghi, M. (2023). Long-term prognosis of patients with heart failure: Follow-up results of Journey HF-TR study population. Anatolian Journal of Cardiology, 27(1), 26-33.

Dae Wook Lee | Cardiovascular Pharmacology | Editorial Board Member

Published on by Cardiology and Cardiovascular Medicine

Dr. Dae Wook Lee | Cardiovascular Pharmacology | Editorial Board Member

Takeda Pharmaceuticals Asia-Pacific | South Korea

Dr. Dae Wook Lee is a senior medical leader serving as Head of Medical Portfolio Management for Rare Disease, Gastroenterology, Plasma-Derived Therapies, Neuroscience, and New Molecular Entities across the Asia-Pacific region at Takeda Pharmaceutical Ltd Pte. With a strong academic foundation that includes a medical degree from the University of Warwick and advanced training in genetic epidemiology and biomedical science, he brings a rigorous scientific perspective to therapeutic development and strategic medical affairs. His clinical research interests center on the genetic underpinnings and innovative analytical approaches relevant to rare diseases, spanning rare hematologic conditions, metabolic disorders such as Fabry and Gaucher diseases, immunologic conditions including hereditary angioedema, and complex neurodevelopmental disorders such as pediatric epilepsy and narcolepsy type 1. In addition, he maintains a strong focus on the etiology and pathophysiology of inflammatory bowel disease, contributing to the advancement of targeted therapies in gastroenterology. Dr. Lee has authored impactful research, including a network meta-analysis evaluating the comparative efficacy and safety of angiotensin II receptor blocker and amlodipine combination therapy in Asian patients with hypertension, as well as a real-world evidence study in ulcerative colitis using exploratory propensity score matching to refine clinical insights. His dedication to scientific advancement is further reflected in his active involvement with the Korean Society of Pharmaceutical Medicine, where he contributes to ongoing innovation in pharmaceutical research and medical strategy.

Profile: Orcid

Featured Publications:

Lee, D. W. (2021). The real-world outcomes of vedolizumab in patients with ulcerative colitis in Korea: A multicenter retrospective study. Therapeutic Advances in Gastroenterology.

Lee, D. W. (2019). Significance of cardiac involvement in Fabry disease. Journal of Cardiology & Cardiovascular Therapy.

Lee, D. W. (2019). Hereditary angioedema and orbital cellulitis: Similarities with dis-similarities. JOJ Ophthalmology.

Lee, D. W., Jung, M., Wang, H. W., Khan, Z., & Pinton, P. (2019). Systematic review with network meta-analysis: Comparative efficacy and safety of combination therapy with angiotensin II receptor blockers and amlodipine in Asian hypertensive patients. International Journal of Hypertension.

Lee, D. W. (2015). Clinical characteristics of patients responding to once-daily basal insulin therapy in Korean subjects with type 2 diabetes. Diabetes Therapy.